Pesquisar | TugaFace

sarthak1234 adicionou um novo artigo Health
2026-07-23 07:26:00

Managing the Complex: How APS-1 Syndrome Treatment is Advancing for Rare Autoimmune Patients
APS-1 syndrome, or Autoimmune Polyglandular Syndrome Type 1, is a rare genetic disorder that epitomizes the complexity of autoimmune disease. Caused by mutations in the AIRE gene, this condition leads to the breakdown of immune tolerance and a multi-organ assault that typically begins in childhood. The Autoimmune Polyglandular Syndrome Type 1 Market is dedicated to providing treatment...

0 Comentários 0 Compartilhamentos 421 Visualizações

Faça Login para curtir, compartilhar e comentar!
sarthak1234 adicionou um novo artigo Health
2026-07-28 07:06:38

Red Blood Cell Disorders: A Comprehensive Market Analysis of Autoimmune Hemolytic Anemia Therapy
Red blood cell disorders encompass a wide range of conditions affecting the production, function, or lifespan of erythrocytes. Among these, autoimmune hemolytic anemia (AIHA) presents a unique clinical challenge due to its autoimmune nature, requiring therapies that modulate the immune system. The market for treating AIHA is expanding, driven by a rising incidence of autoimmune conditions,...

0 Comentários 0 Compartilhamentos 496 Visualizações

Faça Login para curtir, compartilhar e comentar!
ROHITT adicionou um novo artigo Outro
2026-07-08 07:57:39

Autoimmune Biosimilar Drug Market Research Report: Growth Forecast, Competitive Analysis & Emerging Opportunities
Autoimmune Biosimilar Drug Market According to the latest report published by Data Bridge Market Research, the Autoimmune Biosimilar Drug Market The global autoimmune biosimilar drug market size was valued at USD 415.80 million in 2025 and is expected to reach USD 879.70 million by 2033, at a CAGR of 9.80% during the forecast period The market growth is...

0 Comentários 0 Compartilhamentos 835 Visualizações

Faça Login para curtir, compartilhar e comentar!
sarthak1234 adicionou um novo artigo Health
2026-07-30 12:12:27

Autoimmune Blood Disorders: The ITP Therapeutics Market and Treatment Innovations
Autoimmune blood disorders, including immune thrombocytopenia, present significant challenges for patients and healthcare providers, requiring specialized diagnostic and therapeutic approaches. The autoimmune blood disorders treatment market is experiencing significant growth, with projections from USD 2.1 billion in 2025 to USD 3.5 billion by 2035, driven by increasing...

0 Comentários 0 Compartilhamentos 355 Visualizações

Faça Login para curtir, compartilhar e comentar!
InsightsRx adicionou um novo artigo Health
2026-07-06 08:10:26

Biosimilars Market - Immunology Biosimilars and Autoimmune Disease Management
Market Overview The global Biosimilars Market is experiencing explosive growth driven by immunology biosimilar availability, autoimmune disease management evolution, and anti-TNF therapy cost reduction. The global biosimilars market is projected to exceed USD 30 billion through 2030, fueled by adalimumab biosimilar launch, etanercept biosimilar growth, and infliximab biosimilar expansion....

0 Comentários 0 Compartilhamentos 464 Visualizações

Faça Login para curtir, compartilhar e comentar!
sarthak1234 adicionou um novo artigo Health
2026-07-27 10:27:40

From Hospital to Home: The Expanding Role of Autoimmune Vascular Disease and Corticosteroid Treatment
The delivery of giant cell arteritis care has expanded beyond traditional hospital settings, with patients increasingly receiving treatment in outpatient clinics and homecare environments. Autoimmune vascular disease management has evolved to meet the needs of these diverse settings, offering the efficacy, safety, and convenience needed for effective disease control across the care continuum....

0 Comentários 0 Compartilhamentos 457 Visualizações

Faça Login para curtir, compartilhar e comentar!
InsightsRx adicionou um novo artigo Wellness
2026-09-02 09:28:49

How CD47 Antibody Therapies Are Advancing Cancer Immunotherapy, Autoimmune Disease Treatment, and Personalized Medicine
The global leukocyte surface antigen CD47 antibody market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of cancer and improve patient outcomes. The market was valued at USD 1.3 billion in 2025 and is projected to reach USD 3.5 billion by 2035, growing at a CAGR of 10.6%. The...

0 Comentários 0 Compartilhamentos 264 Visualizações

Faça Login para curtir, compartilhar e comentar!
emmaverghise adicionou um novo artigo Outro
2026-09-23 19:32:30

How Diagnostic Innovation Is Improving the Detection of Complex Immune Disorders
The U.S. allergy and autoimmune disease diagnostics Market is witnessing significant transformation, shaped by innovation, evolving consumer expectations, regulatory shifts, and global economic trends. Polaris Market Research’s latest report, U.S. allergy and autoimmune disease diagnostics Market, offers a holistic view of the market. It examines the market’s structure, growth...

0 Comentários 0 Compartilhamentos 306 Visualizações

Faça Login para curtir, compartilhar e comentar!
InsightsRx adicionou um novo artigo Wellness
2026-09-03 07:08:29

How Rising Autoimmune Disease Prevalence and Biologic Therapy Advancements Are Driving the Tildrakizumab Market
The global Tildrakizumab market is expanding as healthcare providers, pharmaceutical companies, and research institutions invest in advanced therapeutic solutions to address the rising incidence of autoimmune diseases and improve patient outcomes. The market was valued at USD 1.2 billion in 2024 and is projected to reach USD 3.8 billion by 2035, growing at a CAGR of 10.2%. The Tildrakizumab...

0 Comentários 0 Compartilhamentos 272 Visualizações

Faça Login para curtir, compartilhar e comentar!
amittil5550 adicionou um novo artigo Outro
2025-12-17 05:58:47

Humira Biosimilar Market to Grow at a CAGR of 22.1% Through 2032
According to a new report published by Introspective Market Research, Humira Biosimilar Market by Product Type, Indication, and Distribution Channel, The Global Humira Biosimilar Market Size Was Valued at USD 0.72 Billion in 2023 and is Projected to Reach USD 4.34 Million by 2032, Growing at a CAGR of 22.1%. Introduction / Market Overview The Humira Biosimilar Market is...

0 Comentários 0 Compartilhamentos 1280 Visualizações

Faça Login para curtir, compartilhar e comentar!

Páginas Impulsionadas